356 related articles for article (PubMed ID: 30905208)
1. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in HIV infection: a metabolic approach of an infectious disease.
Coronel-Castillo CE; Qi X; Contreras-Carmona J; Ramírez-Pérez OL; Méndez-Sánchez N
Expert Rev Gastroenterol Hepatol; 2019 Jun; 13(6):531-540. PubMed ID: 30905208
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease and steatohepatitis in people living with HIV.
Squillace N; Soria A; Bozzi G; Gori A; Bandera A
Expert Rev Gastroenterol Hepatol; 2019 Jul; 13(7):643-650. PubMed ID: 31081390
[No Abstract] [Full Text] [Related]
3. Non-alcoholic fatty liver disease and the metabolic syndrome: an update.
Rector RS; Thyfault JP; Wei Y; Ibdah JA
World J Gastroenterol; 2008 Jan; 14(2):185-92. PubMed ID: 18186553
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
Mikolasevic I; Filipec-Kanizaj T; Mijic M; Jakopcic I; Milic S; Hrstic I; Sobocan N; Stimac D; Burra P
World J Gastroenterol; 2018 Apr; 24(14):1491-1506. PubMed ID: 29662288
[TBL] [Abstract][Full Text] [Related]
5. A gathering storm: HIV infection and nonalcoholic fatty liver disease in low and middle-income countries.
Kapoor N; Audsley J; Rupali P; Sasadeusz J; Paul TV; Thomas N; Lewin SR
AIDS; 2019 Jun; 33(7):1105-1115. PubMed ID: 31045941
[TBL] [Abstract][Full Text] [Related]
6. Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV.
Rockstroh JK
Curr HIV/AIDS Rep; 2017 Apr; 14(2):47-53. PubMed ID: 28284005
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
Dietrich P; Hellerbrand C
Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection.
Maurice JB; Patel A; Scott AJ; Patel K; Thursz M; Lemoine M
AIDS; 2017 Jul; 31(11):1621-1632. PubMed ID: 28398960
[TBL] [Abstract][Full Text] [Related]
9. [Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management].
Kim SK; Kim KI; Kim SR
Yakugaku Zasshi; 2019; 139(9):1147-1153. PubMed ID: 31474630
[TBL] [Abstract][Full Text] [Related]
10. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Sugimoto K; Inui H; Fukusato T
World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
Asrih M; Jornayvaz FR
Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
[TBL] [Abstract][Full Text] [Related]
12. Association of
Toda-Oti KS; Stefano JT; Cavaleiro AM; Carrilho FJ; Correa-Gianella ML; Oliveira CPMS
Metab Syndr Relat Disord; 2022 Mar; 20(2):114-123. PubMed ID: 35020496
[No Abstract] [Full Text] [Related]
13. Human immunodeficiency virus is the major determinant of steatosis and hepatitis C virus of insulin resistance in virus-associated fatty liver disease.
Guaraldi G; Lonardo A; Ballestri S; Zona S; Stentarelli C; Orlando G; Carli F; Carulli L; Roverato A; Loria P
Arch Med Res; 2011 Nov; 42(8):690-7. PubMed ID: 22227046
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.
Manco M
J Am Coll Nutr; 2011 Oct; 30(5):295-303. PubMed ID: 22081615
[TBL] [Abstract][Full Text] [Related]
15. From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management.
Lemoine M; Serfaty L; Capeau J
Curr Opin Infect Dis; 2012 Feb; 25(1):10-6. PubMed ID: 22183113
[TBL] [Abstract][Full Text] [Related]
16. Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus.
Lake JE; Overton T; Naggie S; Sulkowski M; Loomba R; Kleiner DE; Price JC; Chew KW; Chung RT; Corey KE
Clin Gastroenterol Hepatol; 2022 Feb; 20(2):256-268. PubMed ID: 33069882
[TBL] [Abstract][Full Text] [Related]
17. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Fukusato T
World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity.
Walle P; Takkunen M; Männistö V; Vaittinen M; Lankinen M; Kärjä V; Käkelä P; Ågren J; Tiainen M; Schwab U; Kuusisto J; Laakso M; Pihlajamäki J
Metabolism; 2016 May; 65(5):655-666. PubMed ID: 27085774
[TBL] [Abstract][Full Text] [Related]
19. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV.
Lonardo A; Ballestri S; Guaraldi G; Nascimbeni F; Romagnoli D; Zona S; Targher G
World J Gastroenterol; 2016 Nov; 22(44):9674-9693. PubMed ID: 27956792
[TBL] [Abstract][Full Text] [Related]
20. Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?
Paschos P; Athyros VG; Tsimperidis A; Katsoula A; Grammatikos N; Giouleme O
Curr Vasc Pharmacol; 2018; 16(3):269-275. PubMed ID: 28676018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
